SCHEMBL2321959

SCHEMBL2321959

CCN(CC)C1CCN(c2ccc(NS(C)(=O)=O)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.45
ADRB2 P07550 3/20 0.45
ADRB3 P13945 3/20 0.45
JAK2 O60674 3/20 0.45
JAK3 P52333 2/20 0.45
GPR119 Q8TDV5 1/20 0.43
NR3C2 P08235 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 3/20 0.41
HDAC1 Q13547 1/20 0.41
TRPV4 Q9HBA0 1/20 0.41
KCNH2 Q12809 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
EPHX2 P34913 2/20 0.39
NR1H4 Q96RI1 2/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571903 0.82 ADRB1 (0.40) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL9451750 0.81 LSS (0.47) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL9451561 0.79 DRD3 (0.46) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL7301452 0.79 JAK2 (0.64) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL28704613 0.79 JAK2 (0.49) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL5547166 0.78 SMN1; SMN2 (0.39) SMN1; SMN2
Hydrochloric Acid SCHEMBL7307376 0.77 MCHR1 (0.53) ADRB1ADRB2ADRB3NR3C2SMN1; SMN2
SCHEMBL8728925 0.76 ADRB1 (0.46) ADRB1GPR119SMN1; SMN2ALDH1A1LMNA
SCHEMBL7302740 0.76 JAK2 (0.44) ADRB1ADRB2ADRB3JAK2JAK3
SCHEMBL7319744 0.76 KDM4E (0.48) ADRB1ADRB2ADRB3JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4297456-A None JP disclosed
EP-2600863-B1 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA ESTEVE LABOR DR (ES) 2018-03-28 EP disclosed
EP-2646025-B1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN ESTEVE LABOR DR (ES) 2017-03-15 EP disclosed
EP-2571501-B1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY ESTEVE LABOR DR (ES) 2016-03-02 EP disclosed
EP-2460519-A1 Use of sigma ligands in bone cancer pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-06-06 EP disclosed
EP-2353598-A1 Sigma ligands for use in the prevention and/or treatment of postoperative pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-08-10 EP disclosed
EP-0481288-B1 1-Phenylpiperid-4-ylamines and drugs containing them BASF AG (DE) 1995-07-26 EP disclosed
US-5175174-A PHENYLPIPERIDINYLAMINES AND DRUGS CONTAINING THESE BASF AKTIENGESELLSCHAFT (DE) 1992-12-29 US disclosed
JP-H04297456-A PHENYLPIPERIDINYLAMINE BASF AG 1992-10-21 JP disclosed
EP-0481288-A2 1-Phenylpiperid-4-ylamines and drugs containing them BASF Aktiengesellschaft (DE) 1992-04-22 EP disclosed